NI-RADS | Recurrence | Fisher’s exact test | Cramér’s (V) | Linear by linear association | ||||
---|---|---|---|---|---|---|---|---|
Positive recurrence (PPV%) | Negative recurrence rate (NPV%) | Value | P | Value | P | Value | P | |
Primary lesion | Â | Â | 9.90 | 0.005 | 0.486 | 0.003 | 10.06 | 0.002 |
 NI-RADS 1 | 2/22 (9.1%) | 20/22 (90.9%) |  |  |  |  |  |  |
 NI-RADS 2 | 5/17 (29.4%) | 12/17 (70.6%) |  |  |  |  |  |  |
 NI-RADS 3 | 5/7 (71.4%) | 2/7 (28.6%) |  |  |  |  |  |  |
Total | 12/46 (26.1%) | 34/46 (73.9%) | Â | Â | Â | Â | Â | Â |
LN lesion | Â | Â | 9.48 | 0.012 | 0.524 | < 0.012 | 12.33 | 0.006 |
 NI-RADS 1 | 2/40 (5 %) | 38/40 (95 %) |  |  |  |  |  |  |
 NI-RADS 2 | 1/3 (33.3%) | 2/3 (66.7%) |  |  |  |  |  |  |
 NI-RADS 3 | 2/3 (66.7%) | 1/3 (33.3%) |  |  |  |  |  |  |
Total | 5/46 (10.9%) | 41/46 (89.1%) | Â | Â | Â | Â | Â | Â |
Combined primary and LN | Â | Â | 21.61 | < 0.000 | 0.525 | < 0.000 | 24.5 | < 0.000 |
 NI-RADS 1 | 4/62 (6.5%) | 58/62 (93.5%) |  |  |  |  |  |  |
 NI-RADS 2 | 6/20 (30%) | 14/20 (70%) |  |  |  |  |  |  |
 NI-RADS 3 | 7/10 (70%) | 3/10 (30%) |  |  |  |  |  |  |
Total | 17/92 (18.5%) | 75/92 (81.5%) | Â | Â | Â | Â | Â | Â |